

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.05825527 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 6.47789244 |
| 3 | regulation of integrin activation (GO:0033623) | 6.35208622 |
| 4 | transcription from mitochondrial promoter (GO:0006390) | 6.13713768 |
| 5 | proline metabolic process (GO:0006560) | 5.89526068 |
| 6 | positive regulation of protein homooligomerization (GO:0032464) | 5.33270843 |
| 7 | replication fork processing (GO:0031297) | 4.67413758 |
| 8 | cellular response to zinc ion (GO:0071294) | 4.57130814 |
| 9 | regulation of protein homooligomerization (GO:0032462) | 4.44770096 |
| 10 | oxidative demethylation (GO:0070989) | 4.07814151 |
| 11 | DNA deamination (GO:0045006) | 4.04263839 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.01859300 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.01859300 |
| 14 | establishment of apical/basal cell polarity (GO:0035089) | 3.97845826 |
| 15 | embryonic placenta development (GO:0001892) | 3.90037634 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.77586358 |
| 17 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.76533937 |
| 18 | positive regulation of protein oligomerization (GO:0032461) | 3.67409772 |
| 19 | cellular response to ATP (GO:0071318) | 3.65189286 |
| 20 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.64813277 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.64724994 |
| 22 | response to peptidoglycan (GO:0032494) | 3.53720856 |
| 23 | signal complex assembly (GO:0007172) | 3.51312455 |
| 24 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.48625017 |
| 25 | mitochondrial DNA metabolic process (GO:0032042) | 3.47581072 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44829108 |
| 27 | negative regulation of stress fiber assembly (GO:0051497) | 3.44690784 |
| 28 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.38159138 |
| 29 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.36998080 |
| 30 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.34781358 |
| 31 | regulation of macrophage chemotaxis (GO:0010758) | 3.31676677 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28111310 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23944444 |
| 34 | apoptotic process involved in morphogenesis (GO:0060561) | 3.17441281 |
| 35 | establishment of monopolar cell polarity (GO:0061162) | 3.17138102 |
| 36 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.17138102 |
| 37 | face development (GO:0060324) | 3.14956314 |
| 38 | regulation of protein oligomerization (GO:0032459) | 3.14091637 |
| 39 | negative regulation of cell cycle arrest (GO:0071157) | 3.13993563 |
| 40 | membrane invagination (GO:0010324) | 3.12906929 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.12714067 |
| 42 | positive regulation of T cell apoptotic process (GO:0070234) | 3.10382075 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 3.10104359 |
| 44 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.10047021 |
| 45 | positive regulation of receptor recycling (GO:0001921) | 3.09732997 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 3.09376424 |
| 47 | negative regulation of protein oligomerization (GO:0032460) | 3.07437263 |
| 48 | DNA strand renaturation (GO:0000733) | 3.06812558 |
| 49 | anatomical structure regression (GO:0060033) | 3.05921515 |
| 50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05692378 |
| 51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05692378 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 3.05692378 |
| 53 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05692378 |
| 54 | modulation by symbiont of host defense response (GO:0052031) | 3.05692378 |
| 55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05692378 |
| 56 | apoptotic cell clearance (GO:0043277) | 3.03854407 |
| 57 | positive regulation of developmental pigmentation (GO:0048087) | 2.99955531 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 2.97617460 |
| 59 | regulation of response to reactive oxygen species (GO:1901031) | 2.97362931 |
| 60 | regulation of podosome assembly (GO:0071801) | 2.97199285 |
| 61 | regulation of mononuclear cell migration (GO:0071675) | 2.95805651 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91895971 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 2.90303919 |
| 64 | glial cell migration (GO:0008347) | 2.89559829 |
| 65 | mitotic G1/S transition checkpoint (GO:0044819) | 2.88146927 |
| 66 | tolerance induction (GO:0002507) | 2.87981424 |
| 67 | negative regulation of granulocyte differentiation (GO:0030853) | 2.87800926 |
| 68 | detection of other organism (GO:0098543) | 2.87186107 |
| 69 | detection of molecule of bacterial origin (GO:0032490) | 2.86799382 |
| 70 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.86040230 |
| 71 | protein localization to endosome (GO:0036010) | 2.83912040 |
| 72 | activation of Rac GTPase activity (GO:0032863) | 2.83782510 |
| 73 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.83605653 |
| 74 | glycosphingolipid catabolic process (GO:0046479) | 2.83278436 |
| 75 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.83233378 |
| 76 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.80321019 |
| 77 | protein targeting to vacuole (GO:0006623) | 2.80212026 |
| 78 | protein targeting to lysosome (GO:0006622) | 2.80212026 |
| 79 | establishment of protein localization to vacuole (GO:0072666) | 2.80212026 |
| 80 | amino sugar catabolic process (GO:0046348) | 2.80191400 |
| 81 | detection of bacterium (GO:0016045) | 2.79956472 |
| 82 | convergent extension (GO:0060026) | 2.78102754 |
| 83 | mRNA cleavage (GO:0006379) | 2.77548671 |
| 84 | regulation of translational fidelity (GO:0006450) | 2.74615753 |
| 85 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.74300796 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 2.74157916 |
| 87 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74152640 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73876916 |
| 89 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73876916 |
| 90 | G1 DNA damage checkpoint (GO:0044783) | 2.73491929 |
| 91 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.72063907 |
| 92 | embryonic eye morphogenesis (GO:0048048) | 2.71880665 |
| 93 | detection of external biotic stimulus (GO:0098581) | 2.71436592 |
| 94 | base-excision repair (GO:0006284) | 2.71091590 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70973748 |
| 96 | germinal center formation (GO:0002467) | 2.70779304 |
| 97 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.70638947 |
| 98 | embryonic camera-type eye development (GO:0031076) | 2.69875635 |
| 99 | N-glycan processing (GO:0006491) | 2.69874730 |
| 100 | leukocyte aggregation (GO:0070486) | 2.69663292 |
| 101 | sulfur amino acid catabolic process (GO:0000098) | 2.69101882 |
| 102 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.68403561 |
| 103 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.68403561 |
| 104 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68189992 |
| 105 | negative regulation of interleukin-8 production (GO:0032717) | 2.68113359 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.68099613 |
| 107 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67638663 |
| 108 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.67349504 |
| 109 | positive regulation of mast cell activation (GO:0033005) | 2.67196177 |
| 110 | pinocytosis (GO:0006907) | 2.66848881 |
| 111 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.66074266 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 2.64208202 |
| 113 | leukotriene biosynthetic process (GO:0019370) | 2.63570037 |
| 114 | positive regulation by host of viral transcription (GO:0043923) | 2.63389535 |
| 115 | trophectodermal cell differentiation (GO:0001829) | 2.62726763 |
| 116 | hypotonic response (GO:0006971) | 2.62056047 |
| 117 | leukocyte cell-cell adhesion (GO:0007159) | 2.62041507 |
| 118 | negative regulation of interleukin-6 production (GO:0032715) | 2.61984211 |
| 119 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61151094 |
| 120 | regulation of mast cell degranulation (GO:0043304) | 2.60415037 |
| 121 | mannose metabolic process (GO:0006013) | 2.59875400 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59380201 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.59376486 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.58458752 |
| 125 | thymic T cell selection (GO:0045061) | 2.58170418 |
| 126 | retinoic acid receptor signaling pathway (GO:0048384) | 2.57584314 |
| 127 | positive regulation of interferon-beta production (GO:0032728) | 2.57526388 |
| 128 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.56508071 |
| 129 | basement membrane organization (GO:0071711) | 2.56481065 |
| 130 | N-acetylneuraminate metabolic process (GO:0006054) | 2.56247668 |
| 131 | glycolipid catabolic process (GO:0019377) | 2.54077909 |
| 132 | negative regulation of viral release from host cell (GO:1902187) | 2.52963729 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.52319821 |
| 134 | regulation of leukocyte degranulation (GO:0043300) | 2.51599753 |
| 135 | cellular response to interferon-beta (GO:0035458) | 2.51502768 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 2.51197642 |
| 137 | protein heterotrimerization (GO:0070208) | 2.50837491 |
| 138 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50172588 |
| 139 | negative regulation of Ras GTPase activity (GO:0034261) | 2.48867658 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48603781 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.47242078 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.45393090 |
| 143 | T cell selection (GO:0045058) | 2.44080578 |
| 144 | oligosaccharide catabolic process (GO:0009313) | 2.42805271 |
| 145 | barbed-end actin filament capping (GO:0051016) | 2.41710265 |
| 146 | hyaluronan catabolic process (GO:0030214) | 2.41070628 |
| 147 | granulocyte activation (GO:0036230) | 2.40394472 |
| 148 | detection of biotic stimulus (GO:0009595) | 2.39349628 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.39312977 |
| 150 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38541244 |
| 151 | cellular extravasation (GO:0045123) | 2.38504355 |
| 152 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37717221 |
| 153 | stress fiber assembly (GO:0043149) | 2.37223351 |
| 154 | response to type I interferon (GO:0034340) | 2.36507772 |
| 155 | semaphorin-plexin signaling pathway (GO:0071526) | 2.35660109 |
| 156 | T-helper 1 type immune response (GO:0042088) | 2.35320114 |
| 157 | negative T cell selection (GO:0043383) | 2.34507632 |
| 158 | cellular response to type I interferon (GO:0071357) | 2.33992151 |
| 159 | type I interferon signaling pathway (GO:0060337) | 2.33992151 |
| 160 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.33670408 |
| 161 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33539098 |
| 162 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32828853 |
| 163 | positive regulation of cholesterol efflux (GO:0010875) | 2.31779391 |
| 164 | peptide catabolic process (GO:0043171) | 2.31233987 |
| 165 | myeloid dendritic cell activation (GO:0001773) | 2.31224940 |
| 166 | adhesion of symbiont to host cell (GO:0044650) | 2.30849067 |
| 167 | virion attachment to host cell (GO:0019062) | 2.30849067 |
| 168 | regulation of antigen processing and presentation (GO:0002577) | 2.30488544 |
| 169 | adhesion of symbiont to host (GO:0044406) | 2.29851053 |
| 170 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.29779485 |
| 171 | modulation by symbiont of host cellular process (GO:0044068) | 2.27812232 |
| 172 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.27194764 |
| 173 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.26151660 |
| 174 | regulation of tolerance induction (GO:0002643) | 2.26057893 |
| 175 | keratan sulfate catabolic process (GO:0042340) | 2.25748866 |
| 176 | positive regulation of antigen processing and presentation (GO:0002579) | 2.25225334 |
| 177 | regulation of type 2 immune response (GO:0002828) | 2.24482733 |
| 178 | neutrophil activation (GO:0042119) | 2.23131026 |
| 179 | regulation of tumor necrosis factor production (GO:0032680) | 2.21536041 |
| 180 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.21454936 |
| 181 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.19490756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.24743640 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84442394 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67153703 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56297544 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53382234 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42207867 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41187851 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.31441250 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27061732 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08708279 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05784855 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04569399 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01668402 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97447799 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96362988 |
| 16 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.94102126 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91639333 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91620125 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85887650 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84437996 |
| 21 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.84086369 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83858634 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83709602 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.82773540 |
| 25 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.79863738 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75653564 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.74224799 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71791165 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71219111 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69362450 |
| 31 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.68786860 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64815406 |
| 33 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64165648 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62831779 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58677369 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58542908 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57426576 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57274586 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54182945 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52880512 |
| 41 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.52825457 |
| 42 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.52825457 |
| 43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.52825457 |
| 44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52511811 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.51057864 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50279566 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49894265 |
| 48 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.47841642 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45843051 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45357174 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44636272 |
| 52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44480270 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43146967 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40675606 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.40566592 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39567545 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37432056 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37220812 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35175558 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34218045 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32722610 |
| 62 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31446795 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.30695240 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30599885 |
| 65 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.30564398 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26857707 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26478786 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26267161 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.24451492 |
| 70 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.24368465 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24117670 |
| 72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23781308 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23632038 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23593766 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23593315 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22963279 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22570856 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21969706 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21330667 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20945492 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20914095 |
| 82 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20869564 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20263678 |
| 84 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19760000 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19687528 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19088438 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18784326 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18310097 |
| 89 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.17672861 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16685329 |
| 91 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16536599 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16470959 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16054429 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14959166 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12173822 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12092276 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.11656379 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10950527 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10850114 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10794726 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10756823 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10556008 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10134578 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10096698 |
| 105 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09967647 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08897899 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08400501 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07406242 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07252680 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07247621 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06662703 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06629318 |
| 113 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05506168 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05085963 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05063453 |
| 116 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04899979 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.04623476 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03456832 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03332767 |
| 120 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03291975 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03191206 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03142836 |
| 123 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02798128 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02447101 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02250325 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02077336 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01717355 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 1.01513528 |
| 129 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01507617 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01444944 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01108480 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00464535 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00212352 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99532364 |
| 135 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99238558 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99146034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.85726396 |
| 2 | * MP0005058_abnormal_lysosome_morphology | 3.69886224 |
| 3 | MP0005171_absent_coat_pigmentation | 2.89106512 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.74866024 |
| 5 | MP0008057_abnormal_DNA_replication | 2.72822553 |
| 6 | MP0000685_abnormal_immune_system | 2.39215047 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.31950771 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.28091191 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.28091191 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.21877662 |
| 11 | MP0002009_preneoplasia | 2.18137863 |
| 12 | MP0006082_CNS_inflammation | 2.10359430 |
| 13 | MP0002405_respiratory_system_inflammati | 1.96198919 |
| 14 | MP0000015_abnormal_ear_pigmentation | 1.95265917 |
| 15 | MP0001835_abnormal_antigen_presentation | 1.92001373 |
| 16 | MP0005464_abnormal_platelet_physiology | 1.89566521 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.88283199 |
| 18 | MP0005451_abnormal_body_composition | 1.80920520 |
| 19 | MP0003453_abnormal_keratinocyte_physiol | 1.80200483 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.74332382 |
| 21 | MP0003828_pulmonary_edema | 1.74101147 |
| 22 | MP0008260_abnormal_autophagy | 1.67362259 |
| 23 | MP0008995_early_reproductive_senescence | 1.66847301 |
| 24 | MP0010030_abnormal_orbit_morphology | 1.62209861 |
| 25 | MP0009840_abnormal_foam_cell | 1.55463991 |
| 26 | MP0002419_abnormal_innate_immunity | 1.53559287 |
| 27 | MP0001790_abnormal_immune_system | 1.52242339 |
| 28 | MP0005387_immune_system_phenotype | 1.52242339 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.51889133 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.50974163 |
| 31 | MP0001800_abnormal_humoral_immune | 1.50484575 |
| 32 | MP0000371_diluted_coat_color | 1.50328100 |
| 33 | MP0009384_cardiac_valve_regurgitation | 1.50191220 |
| 34 | MP0002254_reproductive_system_inflammat | 1.49320175 |
| 35 | MP0004233_abnormal_muscle_weight | 1.48674516 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.47802761 |
| 37 | MP0006054_spinal_hemorrhage | 1.46696197 |
| 38 | MP0003436_decreased_susceptibility_to | 1.46028402 |
| 39 | MP0000490_abnormal_crypts_of | 1.44974914 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.44814667 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.44796977 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.43790013 |
| 43 | MP0000604_amyloidosis | 1.40893899 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.38683769 |
| 45 | MP0001542_abnormal_bone_strength | 1.38364866 |
| 46 | * MP0000689_abnormal_spleen_morphology | 1.37121465 |
| 47 | MP0001873_stomach_inflammation | 1.36501874 |
| 48 | MP0002006_tumorigenesis | 1.34670569 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.34319155 |
| 50 | MP0003045_fibrosis | 1.34131385 |
| 51 | MP0002060_abnormal_skin_morphology | 1.32620633 |
| 52 | MP0003279_aneurysm | 1.32094963 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.30587332 |
| 54 | MP0005025_abnormal_response_to | 1.29199737 |
| 55 | MP0002723_abnormal_immune_serum | 1.28629280 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.28550167 |
| 57 | MP0000767_abnormal_smooth_muscle | 1.28281664 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.26810675 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.25270111 |
| 60 | MP0004858_abnormal_nervous_system | 1.23873588 |
| 61 | MP0001819_abnormal_immune_cell | 1.23443371 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.21956583 |
| 63 | MP0005671_abnormal_response_to | 1.21771460 |
| 64 | MP0002398_abnormal_bone_marrow | 1.21765788 |
| 65 | MP0001853_heart_inflammation | 1.18468953 |
| 66 | MP0001849_ear_inflammation | 1.18330898 |
| 67 | MP0005670_abnormal_white_adipose | 1.17758549 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.16954882 |
| 69 | MP0005023_abnormal_wound_healing | 1.14300814 |
| 70 | MP0000716_abnormal_immune_system | 1.13071897 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.10674142 |
| 72 | MP0005310_abnormal_salivary_gland | 1.10033864 |
| 73 | MP0009764_decreased_sensitivity_to | 1.08273927 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.08201594 |
| 75 | * MP0002722_abnormal_immune_system | 1.07582351 |
| 76 | MP0002933_joint_inflammation | 1.07535564 |
| 77 | MP0003448_altered_tumor_morphology | 1.07014636 |
| 78 | MP0000343_altered_response_to | 1.03493768 |
| 79 | MP0004381_abnormal_hair_follicle | 1.03371506 |
| 80 | MP0003075_altered_response_to | 1.02125621 |
| 81 | MP0003724_increased_susceptibility_to | 1.00697798 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.00370725 |
| 83 | MP0002429_abnormal_blood_cell | 1.00026419 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.96909806 |
| 85 | MP0005365_abnormal_bile_salt | 0.96543852 |
| 86 | MP0003795_abnormal_bone_structure | 0.96019913 |
| 87 | MP0009115_abnormal_fat_cell | 0.95751776 |
| 88 | MP0004947_skin_inflammation | 0.95137279 |
| 89 | MP0004510_myositis | 0.92436907 |
| 90 | MP0005164_abnormal_response_to | 0.92218261 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.91796537 |
| 92 | MP0003283_abnormal_digestive_organ | 0.91194054 |
| 93 | MP0009785_altered_susceptibility_to | 0.91025060 |
| 94 | MP0003329_amyloid_beta_deposits | 0.90817414 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.90396208 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.89361847 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.87382172 |
| 98 | MP0001851_eye_inflammation | 0.87377308 |
| 99 | MP0003303_peritoneal_inflammation | 0.84960536 |
| 100 | MP0002282_abnormal_trachea_morphology | 0.84498601 |
| 101 | MP0004883_abnormal_blood_vessel | 0.84231315 |
| 102 | MP0010307_abnormal_tumor_latency | 0.84096791 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.83551747 |
| 104 | MP0005409_darkened_coat_color | 0.82466206 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.81818068 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.81260212 |
| 107 | MP0002249_abnormal_larynx_morphology | 0.80408967 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.79687162 |
| 109 | MP0002086_abnormal_extraembryonic_tissu | 0.79380652 |
| 110 | MP0000249_abnormal_blood_vessel | 0.78185803 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.77616122 |
| 112 | MP0000579_abnormal_nail_morphology | 0.77313723 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.77185215 |
| 114 | MP0005390_skeleton_phenotype | 0.76545989 |
| 115 | MP0000470_abnormal_stomach_morphology | 0.76539837 |
| 116 | MP0003690_abnormal_glial_cell | 0.76296065 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.75213115 |
| 118 | MP0001958_emphysema | 0.74204391 |
| 119 | MP0003786_premature_aging | 0.73718988 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.72003503 |
| 121 | MP0001243_abnormal_dermal_layer | 0.71904589 |
| 122 | MP0005166_decreased_susceptibility_to | 0.71225990 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.70860325 |
| 124 | MP0000858_altered_metastatic_potential | 0.70537681 |
| 125 | MP0003866_abnormal_defecation | 0.70424070 |
| 126 | MP0004272_abnormal_basement_membrane | 0.69985309 |
| 127 | MP0003091_abnormal_cell_migration | 0.69976903 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.69625771 |
| 129 | MP0000751_myopathy | 0.69333868 |
| 130 | MP0008469_abnormal_protein_level | 0.67884950 |
| 131 | MP0000609_abnormal_liver_physiology | 0.66946068 |
| 132 | MP0001663_abnormal_digestive_system | 0.63872339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.84310726 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.89411153 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.89411153 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.89411153 |
| 5 | * Dysostosis multiplex (HP:0000943) | 4.69151905 |
| 6 | Cerebral aneurysm (HP:0004944) | 4.31755782 |
| 7 | Alopecia of scalp (HP:0002293) | 4.26099852 |
| 8 | Ulnar bowing (HP:0003031) | 3.94787007 |
| 9 | Increased IgM level (HP:0003496) | 3.86344518 |
| 10 | Cervical subluxation (HP:0003308) | 3.75063325 |
| 11 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.72682395 |
| 12 | * Mucopolysacchariduria (HP:0008155) | 3.72682395 |
| 13 | Poikiloderma (HP:0001029) | 3.71465810 |
| 14 | Turricephaly (HP:0000262) | 3.52143824 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.47343501 |
| 16 | Rib fusion (HP:0000902) | 3.41540366 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.39011255 |
| 18 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.36214420 |
| 19 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.36214420 |
| 20 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.36214420 |
| 21 | Loss of speech (HP:0002371) | 3.35123137 |
| 22 | Intestinal fistula (HP:0100819) | 3.34221238 |
| 23 | Rectovaginal fistula (HP:0000143) | 3.29586357 |
| 24 | Rectal fistula (HP:0100590) | 3.29586357 |
| 25 | Thin bony cortex (HP:0002753) | 3.28606075 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.27779160 |
| 27 | Vaginal fistula (HP:0004320) | 3.13029546 |
| 28 | Annular pancreas (HP:0001734) | 3.07657370 |
| 29 | Abnormality of male internal genitalia (HP:0000022) | 3.02807743 |
| 30 | Tongue fasciculations (HP:0001308) | 2.96898596 |
| 31 | Concave nail (HP:0001598) | 2.93631166 |
| 32 | Abnormal hemoglobin (HP:0011902) | 2.93627373 |
| 33 | Albinism (HP:0001022) | 2.89413808 |
| 34 | IgA deficiency (HP:0002720) | 2.86782124 |
| 35 | Muscle fibrillation (HP:0010546) | 2.86540730 |
| 36 | Myocardial infarction (HP:0001658) | 2.84881199 |
| 37 | Colitis (HP:0002583) | 2.83591983 |
| 38 | Clumsiness (HP:0002312) | 2.82163705 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.78735997 |
| 40 | Male infertility (HP:0003251) | 2.75039864 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.73912646 |
| 42 | Premature skin wrinkling (HP:0100678) | 2.72475447 |
| 43 | Facial hemangioma (HP:0000329) | 2.71725108 |
| 44 | Large for gestational age (HP:0001520) | 2.69152860 |
| 45 | Coronal craniosynostosis (HP:0004440) | 2.67327802 |
| 46 | * Joint stiffness (HP:0001387) | 2.66513053 |
| 47 | Vertebral hypoplasia (HP:0008417) | 2.66112656 |
| 48 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.66112656 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.65318806 |
| 50 | Broad face (HP:0000283) | 2.59604359 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.56391108 |
| 52 | Orchitis (HP:0100796) | 2.53414791 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.51946399 |
| 54 | Polycythemia (HP:0001901) | 2.50591165 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46850151 |
| 56 | Nephritis (HP:0000123) | 2.46372917 |
| 57 | Nuclear cataract (HP:0100018) | 2.42751474 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.40389990 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38057393 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.37946248 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.37095698 |
| 62 | Petechiae (HP:0000967) | 2.32159770 |
| 63 | Cheilitis (HP:0100825) | 2.28867333 |
| 64 | Bowing of the arm (HP:0006488) | 2.28194758 |
| 65 | Bowed forearm bones (HP:0003956) | 2.28194758 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.26002085 |
| 67 | Aortic aneurysm (HP:0004942) | 2.25989048 |
| 68 | Glomerulonephritis (HP:0000099) | 2.24738616 |
| 69 | Hematochezia (HP:0002573) | 2.21951880 |
| 70 | Abnormal platelet volume (HP:0011876) | 2.20935502 |
| 71 | Congenital hip dislocation (HP:0001374) | 2.20639454 |
| 72 | Biconcave vertebral bodies (HP:0004586) | 2.19466951 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.17231614 |
| 74 | Prolonged bleeding time (HP:0003010) | 2.16644103 |
| 75 | Hypokinesia (HP:0002375) | 2.15619309 |
| 76 | Short humerus (HP:0005792) | 2.14289246 |
| 77 | Optic neuritis (HP:0100653) | 2.13126240 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.13126240 |
| 79 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.12265353 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 2.11198079 |
| 81 | Mesangial abnormality (HP:0001966) | 2.11180941 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.10465190 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.10218425 |
| 84 | Emphysema (HP:0002097) | 2.08227965 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 2.07951029 |
| 86 | Anteriorly placed anus (HP:0001545) | 2.07247419 |
| 87 | Flared iliac wings (HP:0002869) | 2.06505312 |
| 88 | Aneurysm (HP:0002617) | 2.06462249 |
| 89 | Diaphragmatic weakness (HP:0009113) | 2.05841968 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.05010315 |
| 91 | Obstructive sleep apnea (HP:0002870) | 2.05008277 |
| 92 | Increased mean platelet volume (HP:0011877) | 2.03719048 |
| 93 | Axonal loss (HP:0003447) | 2.03325548 |
| 94 | Growth hormone excess (HP:0000845) | 2.02313018 |
| 95 | Spondylolisthesis (HP:0003302) | 2.02108835 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 2.01551465 |
| 97 | Persistence of primary teeth (HP:0006335) | 2.01533290 |
| 98 | Premature rupture of membranes (HP:0001788) | 2.00238016 |
| 99 | Peritonitis (HP:0002586) | 2.00051586 |
| 100 | Purpura (HP:0000979) | 1.99942651 |
| 101 | Generalized amyotrophy (HP:0003700) | 1.99832396 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 1.99232237 |
| 103 | Hypochromic anemia (HP:0001931) | 1.98406752 |
| 104 | Increased CSF protein (HP:0002922) | 1.97567791 |
| 105 | Abnormality of complement system (HP:0005339) | 1.97469560 |
| 106 | Protrusio acetabuli (HP:0003179) | 1.97415556 |
| 107 | Premature loss of primary teeth (HP:0006323) | 1.95337515 |
| 108 | Recurrent skin infections (HP:0001581) | 1.92961082 |
| 109 | Gingivitis (HP:0000230) | 1.90306423 |
| 110 | Amyloidosis (HP:0011034) | 1.90105400 |
| 111 | Aortic regurgitation (HP:0001659) | 1.90067279 |
| 112 | Stomatitis (HP:0010280) | 1.89618896 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 1.89402835 |
| 114 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.89238608 |
| 115 | Vascular tortuosity (HP:0004948) | 1.89044160 |
| 116 | Bone pain (HP:0002653) | 1.89038708 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.88858260 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 1.88750745 |
| 119 | Increased serum ferritin (HP:0003281) | 1.88271959 |
| 120 | Orthostatic hypotension (HP:0001278) | 1.84651664 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83973506 |
| 122 | Aortic dissection (HP:0002647) | 1.83112725 |
| 123 | Long toe (HP:0010511) | 1.81981524 |
| 124 | Menorrhagia (HP:0000132) | 1.81185685 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79539794 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79539794 |
| 127 | Genu recurvatum (HP:0002816) | 1.79486592 |
| 128 | Restrictive lung disease (HP:0002091) | 1.79366220 |
| 129 | * Coarse hair (HP:0002208) | 1.79151457 |
| 130 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78622492 |
| 131 | Mediastinal lymphadenopathy (HP:0100721) | 1.78509463 |
| 132 | Ulnar deviation of the wrist (HP:0003049) | 1.77788569 |
| 133 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.77396953 |
| 134 | Hepatosplenomegaly (HP:0001433) | 1.76735696 |
| 135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76629816 |
| 136 | Recurrent viral infections (HP:0004429) | 1.76239687 |
| 137 | Squamous cell carcinoma (HP:0002860) | 1.76180565 |
| 138 | Intestinal atresia (HP:0011100) | 1.75819089 |
| 139 | Bifid uvula (HP:0000193) | 1.75332851 |
| 140 | Hemoptysis (HP:0002105) | 1.75169410 |
| 141 | Nasal polyposis (HP:0100582) | 1.74170693 |
| 142 | Wormian bones (HP:0002645) | 1.73709358 |
| 143 | Blue sclerae (HP:0000592) | 1.73123179 |
| 144 | Abnormality of the nasal mucosa (HP:0000433) | 1.72460390 |
| 145 | Myositis (HP:0100614) | 1.71598924 |
| 146 | Abnormality of T cell physiology (HP:0011840) | 1.70561897 |
| 147 | Femoral bowing (HP:0002980) | 1.70225426 |
| 148 | Prolonged neonatal jaundice (HP:0006579) | 1.69370736 |
| 149 | Syringomyelia (HP:0003396) | 1.69235729 |
| 150 | Spinal cord lesions (HP:0100561) | 1.69235729 |
| 151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.68995219 |
| 152 | Arterial tortuosity (HP:0005116) | 1.68969290 |
| 153 | * Ovoid vertebral bodies (HP:0003300) | 1.68910115 |
| 154 | Epistaxis (HP:0000421) | 1.68822280 |
| 155 | Spinal muscular atrophy (HP:0007269) | 1.68723063 |
| 156 | Ankle contracture (HP:0006466) | 1.68586186 |
| 157 | Acrocyanosis (HP:0001063) | 1.67736085 |
| 158 | Mitral regurgitation (HP:0001653) | 1.67689865 |
| 159 | Achilles tendon contracture (HP:0001771) | 1.67074780 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.66847293 |
| 161 | Upper limb amyotrophy (HP:0009129) | 1.66847293 |
| 162 | Disproportionate tall stature (HP:0001519) | 1.64993161 |
| 163 | Chronic obstructive pulmonary disease (HP:0006510) | 1.63602026 |
| 164 | Obstructive lung disease (HP:0006536) | 1.63602026 |
| 165 | Stridor (HP:0010307) | 1.62403824 |
| 166 | Abnormality of the thoracic spine (HP:0100711) | 1.62193224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 4.46599021 |
| 2 | DDR2 | 4.10840848 |
| 3 | MAPK15 | 4.08679299 |
| 4 | MAP3K6 | 3.50764940 |
| 5 | FGR | 3.06098973 |
| 6 | BMX | 2.95372320 |
| 7 | MAP3K11 | 2.79565569 |
| 8 | MATK | 2.49003400 |
| 9 | CSK | 2.40973995 |
| 10 | MAP4K1 | 2.32301810 |
| 11 | PRKD2 | 2.19980362 |
| 12 | TRPM7 | 2.17736066 |
| 13 | TRIB3 | 2.14578812 |
| 14 | PDGFRA | 1.93036361 |
| 15 | PIM2 | 1.92176120 |
| 16 | PINK1 | 1.87912373 |
| 17 | RIPK4 | 1.87860498 |
| 18 | TGFBR2 | 1.81670911 |
| 19 | MAP3K3 | 1.81260323 |
| 20 | TYRO3 | 1.78248677 |
| 21 | DYRK1B | 1.76602193 |
| 22 | YES1 | 1.68173378 |
| 23 | MAP3K13 | 1.63014039 |
| 24 | TESK2 | 1.57576951 |
| 25 | DAPK1 | 1.48728904 |
| 26 | CDK6 | 1.48300645 |
| 27 | PIM1 | 1.45070869 |
| 28 | ERN1 | 1.44995717 |
| 29 | SMG1 | 1.40680082 |
| 30 | BLK | 1.39845060 |
| 31 | CSF1R | 1.35244878 |
| 32 | STK10 | 1.33263893 |
| 33 | SIK3 | 1.25048657 |
| 34 | UHMK1 | 1.23807338 |
| 35 | TYK2 | 1.22003756 |
| 36 | TAOK2 | 1.19650455 |
| 37 | RPS6KL1 | 1.16986422 |
| 38 | RPS6KC1 | 1.16986422 |
| 39 | GRK7 | 1.14089527 |
| 40 | IRAK3 | 1.11920803 |
| 41 | KIT | 1.11497243 |
| 42 | RPS6KA6 | 1.11358581 |
| 43 | MAPK11 | 1.10368044 |
| 44 | TBK1 | 1.09748740 |
| 45 | TAOK1 | 1.09263747 |
| 46 | MARK2 | 1.08565662 |
| 47 | TAOK3 | 1.08531992 |
| 48 | CDK7 | 1.03593169 |
| 49 | GSK3A | 1.01723729 |
| 50 | FES | 1.01462128 |
| 51 | MAP3K10 | 1.00698617 |
| 52 | RPS6KA2 | 0.99941373 |
| 53 | NME2 | 0.98360944 |
| 54 | ZAP70 | 0.96605624 |
| 55 | SIK2 | 0.96406420 |
| 56 | IKBKB | 0.94697114 |
| 57 | TESK1 | 0.93865014 |
| 58 | MAPK7 | 0.93756996 |
| 59 | PDPK1 | 0.91274994 |
| 60 | LYN | 0.89789057 |
| 61 | MAP2K2 | 0.89723384 |
| 62 | NEK9 | 0.87985118 |
| 63 | CDC42BPA | 0.86216193 |
| 64 | PDGFRB | 0.84967987 |
| 65 | TTN | 0.82259423 |
| 66 | TXK | 0.81042605 |
| 67 | LCK | 0.78746590 |
| 68 | HIPK2 | 0.78218606 |
| 69 | MAP3K7 | 0.77796511 |
| 70 | MET | 0.77268673 |
| 71 | MAP3K1 | 0.77029145 |
| 72 | PKN2 | 0.74656744 |
| 73 | JAK3 | 0.74499877 |
| 74 | EGFR | 0.74437241 |
| 75 | MOS | 0.73475178 |
| 76 | EEF2K | 0.70820113 |
| 77 | SIK1 | 0.69839238 |
| 78 | JAK1 | 0.69238286 |
| 79 | STK38 | 0.68730091 |
| 80 | MTOR | 0.67071542 |
| 81 | CDK12 | 0.66670766 |
| 82 | MAPK12 | 0.65757291 |
| 83 | MARK3 | 0.65220654 |
| 84 | CAMKK1 | 0.64669981 |
| 85 | JAK2 | 0.64606418 |
| 86 | DMPK | 0.63913807 |
| 87 | MAP2K3 | 0.63901340 |
| 88 | MAP2K6 | 0.62415156 |
| 89 | PDK1 | 0.62079276 |
| 90 | PTK2 | 0.61660711 |
| 91 | BTK | 0.60919033 |
| 92 | CAMK1D | 0.60894887 |
| 93 | CHUK | 0.60402714 |
| 94 | MAP3K14 | 0.59189290 |
| 95 | PRPF4B | 0.58779602 |
| 96 | ITK | 0.55388934 |
| 97 | IRAK4 | 0.53712872 |
| 98 | CAMKK2 | 0.52847355 |
| 99 | EPHA2 | 0.51850265 |
| 100 | LRRK2 | 0.51682012 |
| 101 | AKT3 | 0.51347332 |
| 102 | IRAK2 | 0.51135584 |
| 103 | GRK6 | 0.51026229 |
| 104 | RIPK1 | 0.50426468 |
| 105 | MAPK3 | 0.49741548 |
| 106 | HCK | 0.47480560 |
| 107 | TNK2 | 0.46819960 |
| 108 | PTK2B | 0.46392692 |
| 109 | RPS6KA1 | 0.46051266 |
| 110 | TEC | 0.46018586 |
| 111 | PRKAA2 | 0.45580553 |
| 112 | FGFR3 | 0.45219231 |
| 113 | FLT3 | 0.44579027 |
| 114 | EPHB1 | 0.44310275 |
| 115 | PTK6 | 0.44258816 |
| 116 | INSR | 0.43309702 |
| 117 | MAPKAPK2 | 0.42724539 |
| 118 | CHEK2 | 0.41344265 |
| 119 | STK3 | 0.41114570 |
| 120 | CDK4 | 0.40623865 |
| 121 | CLK1 | 0.40234651 |
| 122 | PRKD1 | 0.39430965 |
| 123 | PHKG2 | 0.38683628 |
| 124 | PHKG1 | 0.38683628 |
| 125 | SYK | 0.38622927 |
| 126 | PRKCD | 0.38492128 |
| 127 | PAK4 | 0.36826942 |
| 128 | MAPK1 | 0.36393811 |
| 129 | PRKAA1 | 0.34484107 |
| 130 | PRKCH | 0.31203626 |
| 131 | PAK2 | 0.31003995 |
| 132 | FGFR4 | 0.30959222 |
| 133 | IKBKE | 0.28934506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.72195548 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.96839399 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 2.94933410 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.58984016 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39731279 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.30003404 |
| 7 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.19292595 |
| 8 | * Lysosome_Homo sapiens_hsa04142 | 2.18675164 |
| 9 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.99360463 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.83730169 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.72271395 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71502280 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.65373903 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63948901 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.60058593 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.58637770 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.54500464 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52884501 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.50265545 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.43430983 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.34429074 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33103525 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.32405983 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31854922 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31363742 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29908415 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.29776998 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28548274 |
| 29 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.27887960 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21763294 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19217061 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16564401 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13596123 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12069779 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.11492764 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10465296 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10113823 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08168720 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.06672592 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.06437613 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06238822 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.04404621 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03423227 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03281403 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02844259 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00987193 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 0.99103771 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98610338 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.98156637 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97567387 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96772161 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94775632 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93644544 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.93370706 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92939346 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92745044 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91849443 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91757251 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91301776 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91275925 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.91101896 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90195840 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.89227574 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88469072 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87721943 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87677487 |
| 67 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87569276 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87533075 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.87495822 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86384731 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85994982 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85361564 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84797082 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84755583 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.81437048 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79622911 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79565058 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77853043 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77434665 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76865506 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76191880 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.75801062 |
| 83 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75638326 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75240414 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73839082 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73190279 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72226678 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.72006221 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71884526 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.71539434 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70903461 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70173357 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69967342 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.69375929 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68283436 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63056265 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61904637 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61693169 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61464600 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61292807 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.58921775 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.58358596 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56913431 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56549764 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56285904 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55297895 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55139598 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55006039 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54783511 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54255267 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53755973 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52825470 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.50348279 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50259883 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49899261 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48699763 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48082632 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.47766057 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.47379948 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47334192 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47262287 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46320539 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45555215 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45399013 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45374771 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45060525 |
| 127 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43205390 |
| 128 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42730797 |
| 129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42639322 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40991513 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40192774 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39971160 |

